“IRBM is an important Italian biotech centre , which is giving a strategic contribution to the development of one of the vaccines against Covid-19 , a very important reality from the scientific point of view at international level.
From November 11-13, we will be attending BIO-Europe in Hamburg. Our Global VP of Sales and Marketing, Heidi Kingdon Jones, and VP of North American Business Development, Michele Luche, will be on hand to talk about our exceptional drug discovery services that take you from target validation through to candidate nomination.
Now in its 25th year, BIO-Europe unites thought leaders from around the world to network and attend a range of insightful talks and workshops covering some of the most important trends in Pharma. [https://www.irbm.com/contact-us/]